These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8558131)

  • 21. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat.
    Zeichner SL; Kim JY; Alwine JC
    J Virol; 1991 May; 65(5):2436-44. PubMed ID: 2016766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat.
    Taylor JP; Pomerantz RJ; Oakes JW; Khalili K; Amini S
    Oncogene; 1995 Jan; 10(2):395-400. PubMed ID: 7838536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell.
    Niikura M; Dornadula G; Zhang H; Mukhtar M; Lingxun D; Khalili K; Bagasra O; Pomerantz RJ
    Oncogene; 1996 Jul; 13(2):313-22. PubMed ID: 8710370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1.
    Majello B; De Luca P; Hagen G; Suske G; Lania L
    Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1.
    Roebuck KA; Brenner DA; Kagnoff MF
    J Clin Invest; 1993 Sep; 92(3):1336-48. PubMed ID: 8376588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human cytomegalovirus product UL44 downregulates the transactivation of HIV-1 long terminal repeat.
    Boccuni MC; Campanini F; Battista MC; Bergamini G; Dal Monte P; Ripalti A; Landini MP
    AIDS; 1998 Mar; 12(4):365-72. PubMed ID: 9520165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
    Chang LJ; McNulty E; Martin M
    J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-kappa B action.
    Biswas DK; Dezube BJ; Ahlers CM; Pardee AB
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):778-86. PubMed ID: 8509980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line.
    Antoni BA; Rabson AB; Kinter A; Bodkin M; Poli G
    Virology; 1994 Aug; 202(2):684-94. PubMed ID: 7913275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.
    Popik W; Pitha PM
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9573-7. PubMed ID: 1719535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages.
    Moses AV; Ibanez C; Gaynor R; Ghazal P; Nelson JA
    J Virol; 1994 Jan; 68(1):298-307. PubMed ID: 8254741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity.
    Kliewer S; Garcia J; Pearson L; Soultanakis E; Dasgupta A; Gaynor R
    J Virol; 1989 Nov; 63(11):4616-25. PubMed ID: 2529378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
    Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.
    Taylor JP; Pomerantz RJ; Raj GV; Kashanchi F; Brady JN; Amini S; Khalili K
    J Virol; 1994 Jun; 68(6):3971-81. PubMed ID: 8189531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
    Roof P; Ricci M; Genin P; Montano MA; Essex M; Wainberg MA; Gatignol A; Hiscott J
    Virology; 2002 Apr; 296(1):77-83. PubMed ID: 12036319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes.
    Margolis DM; Rabson AB; Straus SE; Ostrove JM
    Virology; 1992 Feb; 186(2):788-91. PubMed ID: 1310199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
    J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative pathway for induction of human immunodeficiency virus gene expression: involvement of the general transcription machinery.
    Sakaguchi M; Zenzie-Gregory B; Groopman JE; Smale ST; Kim SY
    J Virol; 1991 Oct; 65(10):5448-56. PubMed ID: 1895393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6.
    Kashanchi F; Thompson J; Sadaie MR; Doniger J; Duvall J; Brady JN; Rosenthal LJ
    Virology; 1994 May; 201(1):95-106. PubMed ID: 8178493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner.
    Wang J; Jones C; Norcross M; Bohnlein E; Razzaque A
    J Virol; 1994 Mar; 68(3):1706-13. PubMed ID: 8107231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.